Skip to main content
Book Chapter

Risk assessment among patients receiving primary ADT for prostate cancer

Springer Singapore, (2018), 13-18
DOI: 10.1007/978-981-10-7013-6_3
0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Many risk assessment tools have been developed for prostate cancer patients. The risk classifications, for example, the D'Amico classification and NCCN classification, are widely used. In addition, a nomogram to predict pathological stage and prognosis has also been developed. In this chapter, J-CAPRA score for all stage of patients treated by androgen depletion therapy is explained in detail.

Author supplied keywords

Cite

CITATION STYLE

APA

Hinotsu, S. (2018). Risk assessment among patients receiving primary ADT for prostate cancer. In Hormone Therapy and Castration Resistance of Prostate Cancer (pp. 13–18). Springer Singapore. https://doi.org/10.1007/978-981-10-7013-6_3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free